Spondyloarthropathies: Archives News of the month
The Relationship Between Metabolic Syndrome and Pain Catastrophizing in Psoriatic Arthritis
Spondyloarthropathies 3 min.
Psoriatic arthritis (PsA) is a complex inflammatory disease that occurs in patients affected by or with a family history of psoriasis (PsO). PsA has heterogeneous clinical features, affecting axial and /or peripheric joints and enthesis [1]. PsA often presents alongside several comorbidities, one of...
The status and correlation factors of fatigue in patients with ankylosing spondylitis (FACIT-F): a cross-sectional study based on the Chinese population
Spondyloarthropathies 6 min.
Ankylosing spondylitis (AS) is a chronic progressive autoimmune disease. As a refractory autoimmune disease worldwide, the prevalence rate of AS in China was about 0.3% [1]. In recent years, fatigue in AS patients has received more and more attention from scholars at home and abroad. A cross-sectional...
Health-related quality of life significantly improved in obese patients with psoriatic arthritis one year after a structured weight loss intervention
Spondyloarthropathies 2 min.
Psoriatic arthritis (PsA) is a heterogenous disease characterized by arthritis, dactylitis, enthesitis and in a minority axial disease [1]. PsA is associated with reduced health-related quality of life (HRQoL), depression and anxiety compared with the general population [2, 3]. Obesity is common in PsA...
Clonorchis sinensis excretory/secretory proteins ameliorate inflammation in rheumatoid arthritis and ankylosing spondylitis
Spondyloarthropathies 5 min.
Inflammatory rheumatoid diseases (IRDs) include various conditions including rheumatoid arthritis (RA), ankylosing spondylitis (AS), systemic lupus erythematosus (SLE) and Bechet’s disease (BD) [1]. Notably, the chronic, progressive nature of RA and AS contributes to an inflammatory process, resulting...
Targeting osteoclast-derived DPP4 alleviates inflammation-mediated ectopic bone formation in ankylosing spondylitis
Spondyloarthropathies 6 min.
Ankylosing spondylitis (AS) is a chronic inflammatory disease that affects the joints and enthesis in the axial skeleton [1, 2]. Clinically, TNF or IL-17 inhibitors can reduce inflammation and slow the progression of ankylosis [3, 4, 5, 6–7]. Pathophysiologically, animal models for inflammatory...
